MVL Medisynth Private Limited

MVL Medisynth Private Limited - pharma in Solapur North, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999PN2011PTC174672 Incorporated 24 November 2011 ROC Pune HQ Solapur North, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2024
₹16.78 Cr
▲ 1% YoY
Net profit · FY 2024
₹6.82 Lakh
Net margin 0.4%
EBITDA · FY 2024
₹2.04 Cr
EBITDA margin 12.2%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹4.5 Cr
Issued & subscribed
Open charges
₹25.76 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
43
Provident fund records

About MVL Medisynth Private Limited

Data last updated:

MVL Medisynth Private Limited is a private limited company based in Solapur North, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 November 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2011PTC174672. Its GSTIN is 27AAHCM5553C1ZJ (Maharashtra). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹4.5 Cr. It is led by directors including Srujan Reddy Gaddam (Whole-Time Director) and Eeshan Reddy Nomula.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Solapur North, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹16.78 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹6.82 Lakh (net margin 0.4%) and EBITDA of ₹2.04 Cr (EBITDA margin 12.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 55% over five years.

The company has about 43 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹25.76 Cr on record.

MVL Medisynth Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-32-0000150). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999PN2011PTC174672
Registration Number 174672
Incorporation Date 24 November 2011
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-32-0000150

CIN history

MVL Medisynth has one previous CIN (Corporate Identification Number): U74999KA2011PTC061337. The current CIN is U74999PN2011PTC174672, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74999PN2011PTC174672Current
U74999KA2011PTC061337Previous

Recognitions & Rankings of MVL Medisynth

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-32-0000150

Contact details

MVL Medisynth Private Limited's registered office is in Solapur North, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Block No. B 1 Balaji Apartment, Behind Kinara Hotel Hotgi Road, Solapur North, Maharashtra, India – 413003
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of MVL Medisynth Private Limited, buy the company report.

Comprehensive company report
MVL Medisynth Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of MVL Medisynth is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of MVL Medisynth Private Limited, buy the company report.

Financials of MVL Medisynth Private Limited

FY 2024 filings available

MVL Medisynth Private Limited reported revenue of ₹16.78 Cr (up 1% YoY) for FY 2024.

Revenue · FY 2024
₹16.78 Cr ▲ 1%
Net profit · FY 2024
₹6.82 Lakh margin 0.4%
EBITDA · FY 2024
₹2.04 Cr margin 12.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 9%
5 years · compounded
▲ 55%
EBITDA CAGR growth
1 year
▼ 9%
3 years · compounded
▼ 9%
5 years · compounded
▲ 129%

Revenue has grown at a compounded annual rate (CAGR) of 55% over five years, including 1% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.04 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.82 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin12.2%
Net Profit Margin0.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of MVL Medisynth Private Limited, buy the company report.

Board of directors of MVL Medisynth Private Limited

MVL Medisynth has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Eeshan Reddy NomulaDirector22 Aug 20179 Years 2 MonthsCurrent
Neha ManthaniDirector01 Aug 20197 Years 2 MonthsCurrent
Tanmai Reddy Srujan Reddy GaddamDirector22 Aug 20179 Years 2 MonthsCurrent
Srujan Reddy GaddamWhole-Time Director22 Aug 20179 Years 2 MonthsCurrent

Peer comparison

MVL Medisynth Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Anuja Healthcare Limited₹16.86 Cr (FY 2025)3.0%Chandigarh, India
Anra Pharmaceuticals Private Limited₹16.84 Cr (FY 2025)74.0%Vellaripatti, Tamil Nadu, India
MVL Medisynth Private Limitedthis company₹16.78 Cr (FY 2024)₹6.82 Lakh0.4%1.0%43Solapur North, Maharashtra, India
Leiutis Pharmaceuticals Private Limited₹16.75 Cr (FY 2020)62.0%Hyderabad, Telangana, India
Salius Pharma Private Limited₹16.74 Cr (FY 2025)17.0%Thane, Maharashtra, India
Merlin Pharma Private Limited₹16.74 Cr (FY 2024)24.0%Mumbai, Maharashtra, India
Surien Pharmaceuticals Private Limited₹16.68 Cr (FY 2025)-18.0%Chennai, Tamil Nadu, India

To see the full peer comparison of MVL Medisynth Private Limited, buy the company report.

Auditor

MVL Medisynth Private Limited is audited by Aherkar & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Aherkar & Co.FY 2023130176

Shareholding

The shareholding of MVL Medisynth Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of MVL Medisynth Private Limited, buy the company report.

Charges & borrowings

Open charges
₹25.76 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹25.76 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
14 Aug 2018100204918Hdfc Bank Limited₹12.76 CrOpen
14 Aug 2018100205442Hdfc Bank Limited₹13 CrOpen

To see the full charge records of MVL Medisynth Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for MVL Medisynth Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

MVL Medisynth Private Limited has a workforce of 43 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
43
Active EPFO establishments
1

GST

MVL Medisynth has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAHCM5553C1ZJMaharashtraActive09 Mar 2018

To see the full GST registrations and return filing status of MVL Medisynth Private Limited, buy the company report.

Recent activity

MVL Medisynth Private Limited has 13 board changes on record since 2013: 4 appointments and 9 cessations. The latest: Srujan Reddy Gaddam ceased to be Director on 25 Feb 2021.

AGM
Mvl Medisynth Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Mvl Medisynth Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Charges
A charge with Hdfc Bank Limited of Rs. 12.76 Cr registered on 14 Aug 2018 with Charge ID 100204918 was modified on 01 Mar 2024.
Ceased
Srujan Reddy Gaddam ceased to be Director.
Ceased
Neha Manthani ceased to be Additional Director.
Ceased
Kalakota Reddy Sharath ceased to be Managing Director.
Appointed
Neha Manthani was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 13.00 Cr registered on 14 Aug 2018 with Charge ID 100205442 was modified on 28 Jan 2019.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.00 Cr with Charge ID 100205442 was registered on 14 Aug 2018.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.76 Cr with Charge ID 100204918 was registered on 14 Aug 2018.
Appointed
Eeshan Reddy Nomula was appointed as Director.
Ceased
Kunduru Raghrram ceased to be Director.

8 earlier events are in the company report.

Frequently asked questions

MVL Medisynth is an active private limited company based in Solapur North, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 November 2011 (15+ years old) and is registered under CIN U74999PN2011PTC174672.

MVL Medisynth has 4 current directors:

The latest financial statements of MVL Medisynth on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of MVL Medisynth is 27AAHCM5553C1ZJ, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of MVL Medisynth is U74999PN2011PTC174672. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

MVL Medisynth was incorporated on 24 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Pune.

The peers of MVL Medisynth by revenue are Anuja Healthcare Limited, Anra Pharmaceuticals Private Limited, Leiutis Pharmaceuticals Private Limited, Salius Pharma Private Limited, Merlin Pharma Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Srujan Reddy Gaddam ceased to be Director on 25 Feb 2021. Neha Manthani ceased to be Additional Director on 28 Sep 2019. Kalakota Reddy Sharath ceased to be Managing Director on 01 Aug 2019. MVL Medisynth has 13 board changes on record in total.

Yes, MVL Medisynth is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-32-0000150).

The registered office of MVL Medisynth is at Block No. B 1 Balaji Apartment, Behind Kinara Hotel Hotgi Road, Solapur North, Maharashtra, India – 413003.

MVL Medisynth operates in the pharma industry, in the drug formulation and development segment.